NCT05328050 Registry for Patients With Achondroplasia / Hypochondroplasia (OMPR-Ach/Hy)
| NCT ID | NCT05328050 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico |
| Condition | Achondroplasia |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2021-09-01 |
| Primary Completion | 2031-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2021-09-01 with a primary completion date of 2031-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This registry is a observational, single-center study designed to collect clinical data on patients with achondroplasia and hypochondroplasia.
Eligibility Criteria
Inclusion Criteria: * Confirmed diagnosis of achondroplasia/hypochondroplasia * Patients (and/or Parents legal guardian when required) able to provide informed consent Exclusion Criteria: * Absence of diagnosis of achondroplasia/hypochondroplasia * Patients (and/or Parents legal guardian when required) not able to provide informed consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05328050 clinical trial?
This trial is open to participants of all sexes, studying Achondroplasia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05328050 currently recruiting?
Yes, NCT05328050 is actively recruiting participants. Contact the research team at mariafrancesca.bedeschi@policlinico.mi.it for enrollment information.
Where is the NCT05328050 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT05328050 clinical trial?
NCT05328050 is sponsored by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico. The trial plans to enroll 200 participants.